Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bhuvana Sunil

Tacoma, WA Medical Doctor

NPI 1457756926 CMS profile 5699154

311 S L St, Tacoma, WA 98405

Open in the dashboard

General payments

$1,023

53 records reported · program years 2019–2025

Research payments

$11,200

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$541,980 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Bhuvana Sunil of Tacoma, WA is reported in the CMS Open Payments database as having received $1,023 across 53 general payments and $11,200 in research payments paid to them. Separately, studies naming them as principal investigator received $541,980 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $465 10
2025 Research $1,750 2
2024 General $25 1
2023 General $81 4
2023 Research $9,450 2
2022 General $13 1
2020 General $59 4
2019 General $380 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bhuvana Sunil
  • Washington median
  • Middle half of Washington
  • National median

In program year 2025, general payments to Bhuvana Sunil were reported at $465. Among 15,799 Washington profiles paid that year, the median was $133 and the middle half received between $42 and $442.

Show as a table
Year Bhuvana Sunil Washington median Middle half National median
2019 $380 $126 $38–$506 $163
2020 $59 $90 $30–$291 $114
2021 $0 $107 $29–$344 $132
2022 $13 $124 $38–$398 $149
2023 $81 $129 $40–$423 $160
2024 $25 $133 $44–$454 $164
2025 $465 $133 $42–$442 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $403 34 payments
  2. Sanofi-Aventis U.S. LLC $250 1 payment
  3. Amphastar Pharmaceuticals, Inc. $102 5 payments
  4. Medtronic, Inc. $53 3 payments
  5. Abbott Laboratories $50 1 payment
  6. Sequel Med Tech, LLC $45 2 payments
  7. Insulet Corporation $42 2 payments
  8. AbbVie, Inc. $28 1 payment
  9. Ferring Pharmaceuticals Inc. $24 2 payments
  10. Rhythm Pharmaceuticals, Inc. $13 1 payment
  11. Other $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $723 51 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $250 1 payment
  3. Long term medical supply or device loan $50 1 payment
Products named General payments · program years 2019–2025
  1. Norditropin Growth Hormone $248 30 payments
  2. INPEN SMART INSULIN DELIVERY SYSTEM $53 3 payments
  3. FREESTYLE INSULINX $50 1 payment
  4. TWIIST $45 2 payments
  5. Omnipod $42 2 payments
  6. LUPRON DEPOT $28 1 payment
  7. Norditropin Growth Hormone $27 2 payments
  8. ZOMACTON $24 2 payments
  9. Tresiba $20 1 payment
  10. BAQSIMI $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sanofi US Services Inc. $9,450 2 payments
  2. Sanofi-Aventis U.S. LLC $1,750 2 payments

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record